Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab
about
Pharmacological treatment options for mast cell activation diseaseAdvances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromesDermatologic uses of omalizumabtitle.Targeted Treatment Options in Mastocytosis.Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.Natural history and treatment of cutaneous and systemic mastocytosis.
P2860
Cutaneous and gastrointestinal symptoms in two patients with systemic mastocytosis successfully treated with omalizumab
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cutaneous and gastrointestinal ...... sfully treated with omalizumab
@en
type
label
Cutaneous and gastrointestinal ...... sfully treated with omalizumab
@en
prefLabel
Cutaneous and gastrointestinal ...... sfully treated with omalizumab
@en
P2860
P356
P1476
Cutaneous and gastrointestinal ...... sfully treated with omalizumab
@en
P2093
Simon Francis Thomsen
Sofie Lieberoth
P2860
P304
P356
10.1155/2015/903541
P577
2015-01-28T00:00:00Z